SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001731122-23-000089
Filing Date
2023-01-27
Accepted
2023-01-27 17:27:54
Documents
4
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A e4368_10ka.htm 10-K/A 401134
2 EXHIBIT 31.1 e4368_ex31-1.htm EX-31.1 11380
3 EXHIBIT 31.2 e4368_ex31-2.htm EX-31.2 11204
4 EXHIBIT 32.1 e4368_ex32-1.htm EX-32.1 5879
  Complete submission text file 0001731122-23-000089.txt   430745
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-37606 | Film No.: 23564438
SIC: 2836 Biological Products, (No Diagnostic Substances)